301 related articles for article (PubMed ID: 33721368)
1. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer.
Kim S; Han Y; Kim SI; Lee J; Jo H; Wang W; Cho U; Park WY; Rando TA; Dhanasekaran DN; Song YS
Mol Carcinog; 2021 May; 60(5):297-312. PubMed ID: 33721368
[TBL] [Abstract][Full Text] [Related]
2. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
3. Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.
Adhikary T; Wortmann A; Finkernagel F; Lieber S; Nist A; Stiewe T; Wagner U; Müller-Brüsselbach S; Reinartz S; Müller R
BMC Genomics; 2017 Mar; 18(1):243. PubMed ID: 28327095
[TBL] [Abstract][Full Text] [Related]
4. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
Kotrbová A; Ovesná P; Gybel' T; Radaszkiewicz T; Bednaříková M; Hausnerová J; Jandáková E; Minář L; Crha I; Weinberger V; Záveský L; Bryja V; Pospíchalová V
Theranostics; 2020; 10(2):537-552. PubMed ID: 31903136
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
6. Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.
da Silva RF; Yoshida A; Cardozo DM; Jales RM; Paust S; Derchain S; Guimarães F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513532
[TBL] [Abstract][Full Text] [Related]
7. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
Chen P; Wang Y; Li J; Bo X; Wang J; Nan L; Wang C; Ba Q; Liu H; Wang H
Clin Transl Med; 2021 Jun; 11(6):e462. PubMed ID: 34185421
[TBL] [Abstract][Full Text] [Related]
8. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
9. Metabolic factors contribute to T-cell inhibition in the ovarian cancer ascites.
Gong Y; Yang J; Wang Y; Xue L; Wang J
Int J Cancer; 2020 Oct; 147(7):1768-1777. PubMed ID: 32208517
[TBL] [Abstract][Full Text] [Related]
10. Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.
Voshtani R; Song M; Wang H; Li X; Zhang W; Tavallaie MS; Yan W; Sun J; Wei F; Ma X
Cancer Lett; 2019 Nov; 465():24-35. PubMed ID: 31491449
[TBL] [Abstract][Full Text] [Related]
11. A single-cell landscape of high-grade serous ovarian cancer.
Izar B; Tirosh I; Stover EH; Wakiro I; Cuoco MS; Alter I; Rodman C; Leeson R; Su MJ; Shah P; Iwanicki M; Walker SR; Kanodia A; Melms JC; Mei S; Lin JR; Porter CBM; Slyper M; Waldman J; Jerby-Arnon L; Ashenberg O; Brinker TJ; Mills C; Rogava M; Vigneau S; Sorger PK; Garraway LA; Konstantinopoulos PA; Liu JF; Matulonis U; Johnson BE; Rozenblatt-Rosen O; Rotem A; Regev A
Nat Med; 2020 Aug; 26(8):1271-1279. PubMed ID: 32572264
[TBL] [Abstract][Full Text] [Related]
12. Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer.
Santos NJ; Barquilha CN; Barbosa IC; Macedo RT; Lima FO; Justulin LA; Barbosa GO; Carvalho HF; Felisbino SL
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445387
[TBL] [Abstract][Full Text] [Related]
13. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
[TBL] [Abstract][Full Text] [Related]
14. Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication.
Shender VO; Pavlyukov MS; Ziganshin RH; Arapidi GP; Kovalchuk SI; Anikanov NA; Altukhov IA; Alexeev DG; Butenko IO; Shavarda AL; Khomyakova EB; Evtushenko E; Ashrafyan LA; Antonova IB; Kuznetcov IN; Gorbachev AY; Shakhparonov MI; Govorun VM
Mol Cell Proteomics; 2014 Dec; 13(12):3558-71. PubMed ID: 25271300
[TBL] [Abstract][Full Text] [Related]
15. HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.
Rowswell-Turner RB; Singh RK; Urh A; Yano N; Kim KK; Khazan N; Pandita R; Sivagnanalingam U; Hovanesian V; James NE; Ribeiro JR; Kadambi S; Linehan DC; Moore RG
J Immunol; 2021 May; 206(10):2478-2488. PubMed ID: 33903172
[TBL] [Abstract][Full Text] [Related]
16. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.
Kim S; Kim B; Song YS
Cancer Sci; 2016 Sep; 107(9):1173-8. PubMed ID: 27297561
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells.
Tonetti CR; de Souza-Araújo CN; Yoshida A; da Silva RF; Alves PCM; Mazzola TN; Derchain S; Fernandes LGR; Guimarães F
Cells; 2021 Jul; 10(7):. PubMed ID: 34359872
[TBL] [Abstract][Full Text] [Related]
18. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.
Kerr EH; Frederick PJ; Egger ME; Stockard CR; Sellers J; DellaManna D; Oelschlager DK; Amm HM; Eltoum IE; Straughn JM; Buchsbaum DJ; Grizzle WE; McNally LR
Ann Surg Oncol; 2013 Sep; 20(9):3059-65. PubMed ID: 23525731
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of syndecan-4 protein expression in colorectal cancer.
Jechorek D; Haeusler-Pliske I; Meyer F; Roessner A
Pathol Res Pract; 2021 Jun; 222():153431. PubMed ID: 34029877
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.
Latifi A; Luwor RB; Bilandzic M; Nazaretian S; Stenvers K; Pyman J; Zhu H; Thompson EW; Quinn MA; Findlay JK; Ahmed N
PLoS One; 2012; 7(10):e46858. PubMed ID: 23056490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
